dc.contributor.author | Cardozo, Carlos. | |
dc.contributor.author | Jiménez, Sonia. | |
dc.contributor.author | Miró, Oscar. | |
dc.contributor.author | Et al. | |
dc.date.accessioned | 2023-09-12T13:28:03Z | |
dc.date.available | 2023-09-12T13:28:03Z | |
dc.date.issued | 2021-06 | |
dc.identifier.citation | Eur J Emerg Med . 2021 Jun 1;28(3):218-226. | es |
dc.identifier.issn | 1473-5695 | |
dc.identifier.uri | https://riu.austral.edu.ar/handle/123456789/2288 | |
dc.description | Disponible: https://journals.lww.com/euro-emergencymed/abstract/2021/06000/incidence,_risk_factors,_clinical_characteristics.13.aspx | es |
dc.description.abstract | Abstract
Background and importance: A higher incidence of venous thromboembolism [both pulmonary embolism and deep vein thrombosis (DVT)] in patients with coronavirus disease 2019 (COVID-19) has been described. But little is known about the true frequency of DVT in patients who attend emergency department (ED) and are diagnosed with COVID-19.
Objective: We investigated the incidence, risk factors, clinical characteristics and outcomes of DVT in patients with COVID-19 attending the ED before hospitalization.
Methods: We retrospectively reviewed all COVID patients diagnosed with DVT in 62 Spanish EDs (20% of Spanish EDs, case group) during the first 2 months of the COVID-19 outbreak. We compared DVT-COVID-19 patients with COVID-19 without DVT patients (control group). Relative frequencies of DVT were estimated in COVID and non-COVID patients visiting the ED and annual standardized incidences were estimated for both populations. Sixty-three patient characteristics and four outcomes were compared between cases and controls.
Results: We identified 112 DVT in 74 814 patients with COVID-19 attending the ED [1.50‰; 95% confidence interval (CI), 1.23-1.80‰]. This relative frequency was similar than that observed in non-COVID patients [2109/1 388 879; 1.52‰; 95% CI, 1.45-1.69‰; odds ratio (OR) = 0.98 [0.82-1.19]. Standardized incidence of DVT was higher in COVID patients (98,38 versus 42,93/100,000/year; OR, 2.20; 95% CI, 2.03-2.38). In COVID patients, the clinical characteristics associated with a higher risk of presenting DVT were older age and having a history of venous thromboembolism, recent surgery/immobilization and hypertension; chest pain and desaturation at ED arrival and some analytical disturbances were also more frequently seen, d-dimer >5000 ng/mL being the strongest. After adjustment for age and sex, hospitalization, ICU admission and prolonged hospitalization were more frequent in cases than controls, whereas mortality was similar (OR, 1.37; 95% CI, 0.77-2.45).
Conclusions: DVT was an unusual form of COVID presentation in COVID patients but was associated with a worse prognosis. | es |
dc.language.iso | en | es |
dc.publisher | Lippincott, Williams & Wilkins [Commercial Publisher] | es |
dc.rights | Attribution-NonCommercial-NoDerivatives 4.0 Internacional | * |
dc.rights.uri | http://creativecommons.org/licenses/by-nc-nd/4.0/ | * |
dc.subject | Clinical characteristics. | es |
dc.subject | Coronavirus disease 2019. | es |
dc.subject | Deep venous thrombosis. | es |
dc.title | Incidence, risk factors, clinical characteristics and outcomes of deep venous thrombosis in patients with COVID-19 attending the Emergency Department: results of the UMC-19-S8 | es |
dc.type | Article | es |